Efficacy and safety of gatifloxacin in elderly outpatients with community-acquired pneumonia.

Diagn Microbiol Infect Dis 2002 Sep;44(1):117-25

Bristol-Myers Squibb Company, Plainsboro, New Jersey, USA.

To evaluate the safety and efficacy of gatifloxacin in adults <65, 65 to 79, or > or =80 years old with community-acquired pneumonia, adult male and female outpatients from general community-based practices were enrolled in an open-label, multicenter, noncomparative study. Gatifloxacin 400 mg once daily was administered for seven to 14 days. Medical history, physical examination, signs and symptoms of infection, Gram stain and culture if specimen available, clinical response, and safety were determined. Of 1655 treated patients, 1103 were at least 65 years old, 405 were 65 to 79, and 147 were at least 80. Patients > or =80 years old presented with chills, chest pain, fever, or headache less often than younger patients. Cure rates were 95.5% for patients <65 years old, 96.2% for those 65 to 79, and 90.2% for those at least 80 years old. Neither the frequency nor susceptibility of isolated pathogens appeared to differ with age. Between 93.7% and 100% of subsets of the two younger groups with verified Streptococcus pneumoniae or Hemophilus influenzae were cured. All oldest-group patients in the subset with verified S. pneumoniae and 71.4% (7) of patients with H. influenzae were cured. Each age group, including current or past smokers and patients receiving medications for concomitant conditions, tolerated treatment well. Gatifloxacin is safe and efficacious in adults of any age with community-acquired pneumonia, including the elderly up to 100 years old and patients with S. pneumoniae including penicillin-resistant strains.

Download full-text PDF

http://dx.doi.org/10.1016/s0732-8893(02)00465-0DOI Listing
September 2002
Save 15% Survey

Similar Publications

RIPK3 Activates MLKL-Mediated Necroptosis and Inflammasome Signaling during Infection.

Am J Respir Cell Mol Biol 2021 Feb 24. Epub 2021 Feb 24.

Weill Cornell Medical College, Medicine/ Pulmonary and Critical Care, New York, New York, United States;

Community-acquired pneumonia is the most common type of pneumonia and remains a leading cause of morbidity and mortality worldwide. Although many different pathogens can contribute to pneumonia, Streptococcus pneumoniae (S. pneumoniae) is one of the common bacterial pathogens that underlie community-acquired pneumonia [1]. Read More

View Article and Full-Text PDF
February 2021

A case report of coronary pulmonary artery fistula detected by transthoracic echocardiography in an elderly patient with dyspnea.

AME Case Rep 2021 25;5:10. Epub 2021 Jan 25.

Nam Can Tho University, School of Medicine, Can Tho, Vietnam.

Coronary pulmonary artery fistula (CPAF) is a rare entity in the population. It may present with multiple clinical settings and in various age ranges. Invasive coronary angiography (ICA), coronary computed tomography angiography (CCTA), and transthoracic echocardiography (TTE) have been reported as diagnostic tools for CPAF. Read More

View Article and Full-Text PDF
January 2021

Kidney disease and mortality in patients with respiratory tract infections: a systematic review and meta-analysis.

Clin Kidney J 2021 Feb 10;14(2):602-611. Epub 2020 Feb 10.

Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.

Background: Respiratory tract infections (RTIs) are a common reason for people to seek medical care. RTIs are associated with high short-term mortality. Inconsistent evidence exists in the association between the presence of kidney disease and the risk of death in patient with RTIs. Read More

View Article and Full-Text PDF
February 2021

Quantitative assessment of erector spinae muscles and prognosis in elderly patients with pneumonia.

Sci Rep 2021 Feb 22;11(1):4319. Epub 2021 Feb 22.

Department of Respiratory Medicine and Infectious Diseases, Oita University Faculty of Medicine, 1-1 Idaigaoka, Hasama-machi, Yufu, Oita, 879-5593, Japan.

Erector spinae muscle (ESM) size has been reported as a predictor of prognosis in patients with some respiratory diseases. This study aimed to assess the association of ESM size on all-cause in-hospital mortality among elderly patients with pneumonia. We retrospectively included patients (age: ≥ 65 years) admitted to hospital from January 2015 to December 2017 for community-acquired pneumonia who underwent chest computed tomography (CT) on admission. Read More

View Article and Full-Text PDF
February 2021

Potential of repurposing chloroquine as an adjunct therapy for melioidosis based on a murine model of Burkholderia pseudomallei infection.

Trop Biomed 2020 Jun;37(2):303-317

School of Biosciences and Biotechnology, Faculty of Science and Technology, Universiti Kebangsaan Malaysia, 43600 UKM, Bangi, Selangor, Malaysia.

Burkholderia pseudomallei is the etiologic agent of melioidosis, a major cause of community-acquired pneumonia and sepsis in the endemic areas. The overall mortality of patients with severe melioidosis remains high due to severe sepsis attributed to overwhelming inflammatory cytokine response in spite of recommended antibiotic therapy. It is crucial that therapeutic approaches beyond just effective antibiotic treatment such as adjunct therapy be considered to mitigate the dysregulated inflammatory signaling and augment host defenses. Read More

View Article and Full-Text PDF